Stock Movers: UnitedHealth Plunges, Eli Lilly Surges, TSMC Rises on Forecast

UnitedHealth's Significant Plunge

• 📉 UnitedHealth shares are down nearly 20%, marking their largest drop since March 2020.
• ⚠️ The company issued its first earnings miss in over a decade and cut its annual forecast, citing unexpected rising medical costs.
• 💡 This guidance cut is unusual for UnitedHealth, as they typically forecast conservatively and tend to raise their outlook throughout the year.
• 📊 Other health insurers in the sector are also experiencing significant declines, with some analysts suggesting UnitedHealth's results cast doubt on the forecasts of the entire industry.

Eli Lilly's Experimental Weight-Loss Pill Success

• 🚀 Eli Lilly shares surged as its experimental weight-loss pill, orforglipron, showed efficacy comparable to Ozempic in trial data.
• 💊 This development brings the company closer to offering a needle-free alternative for weight loss and diabetes management.
• 🎯 The drug is being tested for various conditions including diabetes, obesity, and sleep apnea.
• ✨ The potential for a pill form is seen as a significant advantage over injectable treatments by many patients.

TSMC's Optimistic Outlook

• 📈 TSMC's ADRs are edging higher following the chipmaker's second-quarter sales forecast, which surpassed analyst estimates.
• 🌐 The company maintained its 2025 growth outlook, driven by expectations of AI revenue doubling.
• ⚠️ Despite the positive outlook, some analysts note that the forecast may not fully account for potential impacts from tariffs or the ongoing US-China trade tensions.
• 💡 TSMC's confidence suggests it is positioned to navigate current market challenges.